Home › Funds › Manulife Financial › ROIV
Manulife Financial position in ROIV
ROIVANT SCIENCES LTD · Health Care
Latest position (Q2 2026)2.99M sh
Reported value held$105.75M
Portfolio Weight0.09%
First reportedQ3 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 251.01K | $2.93M | New |
| Q4 2023 | 289.81K | $3.25M | Add |
| Q1 2024 | 399.88K | $4.21M | Add |
| Q2 2024 | 321.96K | $3.40M | Reduce |
| Q3 2024 | 356.60K | $4.12M | Add |
| Q4 2024 | 338.01K | $4.00M | Reduce |
| Q1 2025 | 331.80K | $3.35M | Reduce |
| Q2 2025 | 385.95K | $4.35M | Add |
| Q3 2025 | 467.20K | $7.07M | Add |
| Q4 2025 | 598.51K | $12.97M | Add |
| Q1 2026 | 699.14K | $19.37M | Add |
| Q2 2026 | 2.99M | $105.75M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ROIV
- Fidelity Management & Research (FMR) 81.02M sh · $2.87B · Q2 2026
- BlackRock Inc 48.24M sh · $1.71B · Q2 2026
- Morgan Stanley 42.59M sh · $1.51B · Q2 2026
- Vanguard Group 42.06M sh · $912.68M · Q4 2025
- Goldman Sachs Group 18.56M sh · $656.71M · Q2 2026
- UBS Group AG 17.47M sh · $618.14M · Q2 2026
- Farallon Capital Management 14.31M sh · $506.40M · Q2 2026
- Geode Capital Management 11.67M sh · $425.54M · Q2 2026
- Wells Fargo & Co 9.72M sh · $344.04M · Q2 2026
- Invesco Ltd 7.53M sh · $266.53M · Q2 2026
- AQR Capital Management 6.63M sh · $234.03M · Q2 2026
- Viking Global Investors 6.27M sh · $221.95M · Q2 2026